Current Aspirin News and Events | Page 2

Current Aspirin News and Events, Aspirin News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
Pregnant women with very high blood pressure face greater heart disease risk
Women with high blood pressure in their first pregnancy have a greater risk of heart attack or cardiovascular death, according to a Rutgers study. (2020-02-06)

Choosing common pain relievers: It's complicated
About 29 million Americans use over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) to treat pain. Every year in the US, NSAID use is attributed to approximately 100,000 hospitalizations and 17,000 deaths. All of these drugs have benefits and risks, but deciding which one to use is complicated for health care providers and their patients. To assist in clinical decision-making, researchers address cardiovascular risks and beyond, which include gastrointestinal and kidney side effects of pain relievers. (2020-02-05)

Low-dose aspirin may reduce preterm birth risk among first-time mothers
Daily low-dose aspirin, from as early as the sixth week of pregnancy through the 36th week, may lower the risk for preterm birth among first-time mothers, suggests a study funded by the National Institutes of Health. (2020-01-23)

Aspirin appears to curb colorectal cancer recurrence and tumor growth, study finds
The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and inhibit recurrence of the disease. The trick now, researchers say, is to determine the right dosage of aspirin that can be used as a daily prophylactic without triggering dangerous side effects such as stomach and brain bleeds. (2020-01-06)

Mayo Clinic researchers present findings at the 2019 San Antonio Breast Cancer Symposium
Mayo Clinic researchers will present findings at the San Antonio Breast Cancer Symposium Dec. 10-14 in San Antonio. (2019-12-13)

Low-dose aspirin may not help African-Americans prevent heart attack
Use of daily, low-dose aspirin in persons without known cardiovascular disease was lower among blacks than whites. Taking a daily, low-dose aspirin without known cardiovascular disease was not associated with helping African-American adults reduce their risk of a fatal heart attack. (2019-12-11)

Aspirin's health benefits under scrutiny
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events. (2019-12-09)

Aspirin may no longer be effective as cardiovascular treatment
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin no longer provides a net benefit as primary prevention for cardiovascular disease and cancer. (2019-12-09)

Migraine headaches? Consider aspirin for treatment and prevention
Evidence from 13 randomized trials of the treatment of migraine in 4,222 patients and tens of thousands of patients in prevention of recurrent attacks supports the use of high dose aspirin from 900 to 1,300 milligrams to treat acute migraine as well as low dose daily aspirin from 81 to 325 milligrams to prevent recurrent attacks. Aspirin is available without a prescription, is inexpensive, and has a relatively favorable side effect profile compared to alternative more expensive medications. (2019-12-03)

Got a migraine? Relief may already be on your medicine shelf
According to a new report in The American Journal of Medicine, published by Elsevier, aspirin can be considered an effective and safe option to other, more expensive medications to treat acute migraines as well as prevent recurrent attacks. A review of randomized evidence suggests efficacy and safety of high dose aspirin in doses from 900 to 1,300 milligrams taken at the onset of acute symptoms. The data also support a lower dose of from 81 to 325 milligrams as a possible preventive option. (2019-12-03)

Can aspirin decrease the rate of intracranial aneurysm growth?
Researchers investigated whether aspirin can aid in the prevention of intracranial aneurysm rupture by hindering aneurysm growth. The researchers identified 146 patients harboring multiple intracranial aneurysms, five millimeters or less in diameter, that had been observed for at least five years. In this set of patients, the researchers found an association between aspirin use and a decreased rate of aneurysm growth. Growth is important in intracranial aneurysms because it increases the risk of aneurysm rupture. (2019-10-29)

Changes in microglia impact neuroinflammation and disease pathology
Advances in research about the brain's immune system have helped uncover the underlying foundations of neuroinflammation. These findings were presented at Neuroscience 2019, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health. (2019-10-21)

Aspirin use after biliary tract cancer diagnosis
Researchers in this observational study examined if aspirin use after a diagnosis of a biliary tract cancer, which includes gallbladder cancer, was associated with reduced risk of death among nearly 3,000 patients. (2019-10-17)

Computer kidney sheds light on proper hydration
A new computer kidney developed at the University of Waterloo could tell researchers more about the impacts of medicines taken by people who don't drink enough water. (2019-10-07)

Canadians told to stop taking aspirin to prevent first heart attack, stroke
If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research. Researchers at the University of Alberta Kolber reviewed three large, randomized, placebo-controlled studies published in 2018 that showed the risk of major internal bleeding associated with taking an aspirin a day is higher than any preventative benefits. (2019-10-02)

Aspirin may prevent air pollution harms
A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function. The researchers found that the use of any NSAID nearly halved of the effect of PM on lung function, with the association consistent across all four weekly air pollution measurements from same-day to 28 days prior to the lung function test. (2019-10-02)

Should patients continue blood thinners after experiencing gastrointestinal bleeding?
Anticoagulants and antiplatelet drugs, which are blood thinners such as warfarin and aspirin, are commonly taken to reduce the risk of potentially fatal blood clots, but they carry an increased risk of gastrointestinal bleeding. A study of 871 patients from Spain published in Alimentary Pharmacology and Therapeutics has shown that patients who restart their blood thinners after such a bleed have a 39% reduced risk of dying over the next 2 years even though their risk of recurrent gastrointestinal bleeding increased. (2019-09-05)

For patients with diabetes, ticagrelor reduced heart attacks, strokes
In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals -- AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS). (2019-09-01)

Aspirin should not be recommended for healthy people over 70
Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those at the highest risk of cardiovascular disease. The late breaking results of the ASPREE trial are presented today at ESC Congress 2019 together with the World Congress of Cardiology. (2019-08-31)

Study analyzes outcomes of dual antiplatelet therapy after minor stroke or TIA
An analysis of combined patient-level data from two randomized clinical trials  examined outcomes of dual antiplatelet therapy with clopidogrel and aspirin after minor stroke or transient ischemic attack. (2019-08-19)

How plants synthesize salicylic acid
The pain-relieving effect of salicylic acid has been known for thousands of years. Besides being a useful drug with numerous health applications, it is a stress hormone made by plants, which is essential for them to fight off damaging pathogens. What was not known, is how plants generated this hormone. Now, an international research team led by the University of Göttingen has unravelled the biosynthesis of this crucial hormone. The results were published in Science. (2019-08-13)

Aspirin may help some breast cancer survivors, but changes in DNA may mean harm for others
Previous studies have shown that while some women who use aspirin and are later diagnosed with breast cancer may live longer, a portion of aspirin users with breast cancer appeared to have a higher risk of mortality following breast cancer. According to a new study from the University of North Carolina at Chapel Hill Gillings School of Global Public Health, the reason for this reverse effect could be explained by DNA methylation of genes in breast cancer tumors or peripheral blood. (2019-08-12)

Aspirin may interact with cells' DNA modifications to alter breast cancer outcomes
New findings suggest that women with specific DNA characteristics in certain areas of the genome may live longer if they take aspirin before they are diagnosed with breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for studies on the potential of aspirin to prevent or treat breast cancer in some individuals. (2019-08-12)

Shrinking brain tumours and opening the door for targeted cancer therapies
A new drug, known as IP1867B, could be used for future treatments of brain tumours. The research team showed that IP1867B worked with existing cancer treatments boosting their effectiveness and, in some cases, restored sensitivity to some treatments. (2019-08-05)

Aspirin improves liver function after embolization of hepatocellular carcinoma
Aspirin therapy is associated with both improved liver function test results and survival after transarterial embolization for hepatocellular carcinoma, according to an ahead-of-print article by F. Edward Boas of Memorial Sloan Kettering Cancer published in the September 2019 issue of the American Journal of Roentgenology (AJR). (2019-07-31)

University of Guelph researchers unlock access to pain relief potential of cannabis
University of Guelph researchers have uncovered how the cannabis plant creates pain-relieving molecules that are 30 times more powerful at reducing inflammation than Aspirin. The discovery unlocks the potential to create a naturally derived pain treatment. (2019-07-23)

Researchers find widespread aspirin use despite few benefits, high risks
Nearly 30 million Americans older than 40 take aspirin daily to prevent cardiovascular disease. More than 6 million Americans take aspirin daily without physician's recommendation. Nearly half of Americans more than 70 years of age without cardiovascular disease, an estimate of nearly 10 million people, take aspirin daily -- despite current guidelines against this practice. (2019-07-22)

Recycling plastic: Vinyl polymer broken down to aspirin components
Not a day goes by without news of microplastics in our oceans. There are not many efficient methods of recycling plastics without compromising quality. A beacon of hope was recently lit at Shinshu University where researchers discovered acid hydrolysis of a vinyl polymer breaks down into salicylic acid and acetic acid, precursors to dehydroaspirin which in theory can be made into vinyl polymers again. (2019-07-01)

Aspirin green light for brain bleed stroke patients, study finds
People who suffer a stroke caused by bleeding in the brain -- known as brain haemorrhage -- can take common medicines without raising their risk of another stroke, a major clinical trial has found. Researchers say the findings are reassuring for the thousands of people who take the medicines to reduce their risk of heart attack and another common type of stroke caused by blood clots in the brain. (2019-05-22)

Aspirin before at-home colorectal cancer screening test didn't significantly improve ability to detect cancer precursors
Some observational studies have suggested that taking aspirin before undergoing colorectal cancer screening with a fecal immunochemical test for blood in stool might improve the ability of the test to detect cancer precursors. (2019-05-07)

Aspirin to fight an expensive global killer infection
Tuberculosis is far from eradicated around the world and still infects more than 1,400 people per year in Australia. Antibiotic resistant tuberculosis is particularly deadly and expensive to treat, costing up to $250,000 to treat a single case in Australia. Scientists at the Centenary Institute have been working on new ways to treat tuberculosis by increasing the effectiveness of the immune system. (2019-03-25)

Apixaban plus P2Y12 inhibitor and no aspirin safest for patients with both AFib and ACS
Patients at high risk for heart attacks, strokes and blood clots who were treated with a novel blood thinner (apixaban) and an antiplatelet drug such as clopidogrel had a significantly lower risk of bleeding and being hospitalized compared with patients who received an older blood-thinning medication such as warfarin, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-18)

ACC/AHA guidance for preventing heart disease, stroke released
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy eating plan, getting more exercise, avoiding tobacco and managing known risk factors are among the key recommendations in the 2019 Primary Prevention of Cardiovascular Disease guideline from the American College of Cardiology (ACC) and the American Heart Association (AHA). Also, it is recommended that aspirin should only rarely be used to help prevent heart attacks and stroke in people without known cardiovascular disease. (2019-03-18)

Stopping DAPT after one-month improved outcomes in stent patients
Patients who stopped taking aspirin one month after receiving a stent in the heart's arteries but continued taking the P2Y12 inhibitor clopidogrel fared significantly better after one year compared with those who followed the standard practice of continuing both medications, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-18)

Stopping aspirin three months after stenting does not increase risk of death
Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor -- clopidogrel, prasugrel or ticagrelor -- did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. Furthermore, patients who stopped taking aspirin after three months had a significantly lower rate of bleeding. (2019-03-18)

'Inflamm-aging' causes loss of bone healing ability in the elderly
Increases in chronic inflammation -- not the passage of time -- is the main reason why injured bones do not heal as well with age. (2019-03-18)

CT scans offer clues to preventing heart problems after cancer treatment
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's risk for heart problems in the months and years after treatment. However, this information is not always reported and is rarely acted upon in current practice, according to research being presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-06)

Study: More than one-third of patients risk major bleeding by doubling up on blood thinners
A new study finds patients were taking too many antithrombotics for no reason, leading to a significant increase in bleeding events. (2019-03-04)

A tasty Florida butterfly turns sour
A 15-year study led by University of Arizona entomologist Katy Prudic found that, when living apart from the unsavory bug it mimics, the viceroy butterfly becomes yucky, making biologists rethink old theories about animal mimicry. (2019-02-22)

10 percent of Chinese adults have high heart disease risk, aren't treated for it
Researchers at Yale and at the National Center for Cardiovascular Disease in China just quantified a significant opportunity to improve Chinese heart health: 1 in 10 middle-aged Chinese adults are at high risk for heart disease, yet only about 3 percent of those at-risk are taking either statins or aspirin, the recommended therapies for managing that risk. This study was published in the Annals of Internal Medicine. (2019-02-21)

Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.